LVP and SVP formulation considerations MCQs With Answer

LVP and SVP formulation considerations MCQs With Answer

Formulating Large Volume Parenterals (LVPs) and Small Volume Parenterals (SVPs) demands a rigorous understanding of sterility assurance, endotoxin control, particulate limits, container–closure compatibility, and clinical tolerability. This MCQ set is designed for M. Pharm students to sharpen decision-making on key design choices such as terminal sterilization vs. aseptic processing, buffer and tonicity selection, material compatibility (glass/plastics), and preservative use. You will also encounter scenario-driven questions on IV emulsion quality metrics, lyophilization aids, endotoxin calculations, and prevention of precipitation in parenteral nutrition. Each question targets practical, regulation-aligned formulation decisions, grounding you in USP/Ph. Eur. expectations and cGMP realities. Use these MCQs to test depth, not just recall.

Q1. What is the most accepted volume-based classification distinguishing LVP from SVP?

• Products with fill volume ≥100 mL are LVP; ≤100 mL are SVP
• LVP is defined as >500 mL only
• SVP is defined as ≤10 mL only
• Classification is based on drug potency, not volume

Correct Answer: Products with fill volume ≥100 mL are LVP; ≤100 mL are SVP

Q2. Which statement on antimicrobial preservatives is most appropriate for parenterals?

• LVP must not contain bacteriostatic preservatives due to risk of toxicity
• LVP commonly include benzyl alcohol 0.9% for safety
• SVP single-dose containers must contain preservatives
• Preservatives are mandatory for all parenterals

Correct Answer: LVP must not contain bacteriostatic preservatives due to risk of toxicity

Q3. Regarding sterilization strategy for parenterals, which is preferred when feasible?

• Terminal moist-heat sterilization at 121 °C is preferred whenever product can withstand it
• Aseptic filtration is always preferred over terminal sterilization
• Dry heat sterilization is used for aqueous LVP solutions
• Gamma irradiation is routine for all SVPs

Correct Answer: Terminal moist-heat sterilization at 121 °C is preferred whenever product can withstand it

Q4. In aseptic processing of SVPs, which approach ensures microbial retention and verification?

• 0.22 µm sterilizing-grade filtration followed by filter integrity test (e.g., bubble point) is standard for aseptically filled SVPs
• 0.45 µm membrane ensures sterility for all parenterals
• Integrity testing is optional if process is validated
• 5.0 µm filter ensures depyrogenation

Correct Answer: 0.22 µm sterilizing-grade filtration followed by filter integrity test (e.g., bubble point) is standard for aseptically filled SVPs

Q5. Which statement best reflects the principle for calculating endotoxin limits for injections?

• Bacterial endotoxin limit is calculated as K/M, where K is 5 EU/kg for IV and 0.2 EU/kg for intrathecal
• Endotoxin limits are fixed at 0.25 EU/mL for all parenterals
• Endotoxin testing is not required for LVP
• K/M uses K = 50 EU/kg for IV

Correct Answer: Bacterial endotoxin limit is calculated as K/M, where K is 5 EU/kg for IV and 0.2 EU/kg for intrathecal

Q6. What is the USP <788> particulate matter limit for large-volume injections by light obscuration?

• For large-volume injections, NMT 25 particles ≥10 µm/mL and NMT 3 particles ≥25 µm/mL by light obscuration
• For large-volume injections, NMT 6000 particles ≥10 µm per container
• Limits are the same for LVP and SVP
• Only microscopic method applies to LVP

Correct Answer: For large-volume injections, NMT 25 particles ≥10 µm/mL and NMT 3 particles ≥25 µm/mL by light obscuration

Q7. What is the USP <788> limit for particulate matter in small-volume injections by light obscuration?

• For small-volume injections, NMT 6000 particles ≥10 µm/container and NMT 600 particles ≥25 µm/container by light obscuration
• For SVP, limits are per mL
• For SVP, NMT 25 particles ≥10 µm/mL
• Particulate testing is waived if solution is clear

Correct Answer: For small-volume injections, NMT 6000 particles ≥10 µm/container and NMT 600 particles ≥25 µm/container by light obscuration

Q8. Which statement best guides buffer selection for LVPs?

• Use minimal buffering capacity; prefer acetate/citrate over phosphate to reduce precipitation risk
• Strong phosphate buffers are preferred to maintain constant pH
• Borate buffer is ideal for all IV infusions
• LVP should not be buffered

Correct Answer: Use minimal buffering capacity; prefer acetate/citrate over phosphate to reduce precipitation risk

Q9. What is the desired tonicity range for peripheral IV LVPs?

• Target osmolality for peripheral IV LVP is approximately 275–310 mOsm/kg
• Hypertonic LVPs (>900 mOsm/kg) are suitable for peripheral veins
• Hypotonic LVPs (<150 mOsm/kg) are well tolerated
• Tonicity adjustment is unnecessary for parenterals

Correct Answer: Target osmolality for peripheral IV LVP is approximately 275–310 mOsm/kg

Q10. Which pH range is commonly targeted in LVPs to balance stability and tolerability?

• pH 4–8 is a common target for LVP to balance stability and minimize irritation
• pH 1–3 is acceptable for most IV LVPs without irritation
• All IV injections must be at physiological pH 7.40
• pH control is irrelevant for SVPs

Correct Answer: pH 4–8 is a common target for LVP to balance stability and minimize irritation

Q11. Which packaging selection is most appropriate based on formulation reactivity?

• Type II (treated soda-lime) glass is acceptable for acidic/neutral SVPs; Type I borosilicate is preferred for alkaline or sensitive products
• Type III glass is suitable for most aqueous injections
• Plastic bags are unacceptable for LVPs
• Type I borosilicate should never be used for SVPs

Correct Answer: Type II (treated soda-lime) glass is acceptable for acidic/neutral SVPs; Type I borosilicate is preferred for alkaline or sensitive products

Q12. Which statement on adsorption and infusion materials is correct?

• Drugs like nitroglycerin and diazepam adsorb to PVC; use glass or non-PVC polyolefin bags/tubing
• Adsorption is not a concern in LVPs
• PVC is universally compatible with all drugs
• Using surfactant eliminates adsorption concerns completely

Correct Answer: Drugs like nitroglycerin and diazepam adsorb to PVC; use glass or non-PVC polyolefin bags/tubing

Q13. What is the preservative consideration for neonatal parenterals?

• Benzyl alcohol should be avoided in neonatal parenterals due to toxicity (“gasping syndrome”)
• Phenol is safe in all neonatal SVPs
• Multidose SVPs are preferred in neonates for convenience
• Preservatives have no impact on neonatal safety

Correct Answer: Benzyl alcohol should be avoided in neonatal parenterals due to toxicity (“gasping syndrome”)

Q14. Which is the correct statement about multidose parenteral container size?

• Maximum volume for a multidose parenteral container is generally 30 mL
• Multidose LVPs are 250–1000 mL
• Multidose SVPs must be at least 50 mL
• There is no limit on multidose container size

Correct Answer: Maximum volume for a multidose parenteral container is generally 30 mL

Q15. For minimizing oxidation in parenterals, which practice is preferred, especially for LVPs?

• Antioxidants and chelators are generally avoided in LVPs; oxygen control (e.g., nitrogen overlay) is preferred
• High levels of sulfites are routinely added to LVPs
• Antioxidants are mandatory in all SVPs
• Removing headspace oxygen has no effect on oxidation

Correct Answer: Antioxidants and chelators are generally avoided in LVPs; oxygen control (e.g., nitrogen overlay) is preferred

Q16. In SVP lyophilization, which statement is accurate regarding formulation aids?

• Cryo/lyoprotectants such as sucrose, trehalose, or mannitol are used in SVP lyophilization to stabilize proteins and form elegant cakes
• Lyophilization is unsuitable for SVPs
• Sodium chloride is the preferred bulking agent for lyophilized biologics
• Lyophilized SVPs are terminally sterilized by moist heat after drying

Correct Answer: Cryo/lyoprotectants such as sucrose, trehalose, or mannitol are used in SVP lyophilization to stabilize proteins and form elegant cakes

Q17. Which quality criteria apply to IV lipid emulsions per USP <729>?

• IV lipid emulsions must have mean droplet diameter ≤500 nm and PFAT5 ≤0.05% per USP <729>
• Emulsion droplet size may exceed 5 µm without risk
• PFAT5 measures particles larger than 50 µm
• Emulsions need not meet any globule size tests

Correct Answer: IV lipid emulsions must have mean droplet diameter ≤500 nm and PFAT5 ≤0.05% per USP <729>

Q18. Which statement best reflects current expectations for Container-Closure Integrity Testing (CCIT)?

• Deterministic methods (e.g., vacuum decay, helium leak) are preferred for container-closure integrity over dye ingress alone
• CCIT is unnecessary if sterility test passes
• Only dye ingress is accepted by regulators
• Visual inspection replaces CCIT for SVPs

Correct Answer: Deterministic methods (e.g., vacuum decay, helium leak) are preferred for container-closure integrity over dye ingress alone

Q19. Which is true regarding Water for Injection (WFI) used in parenteral manufacture?

• Bulk Water for Injection is not sterile but must meet endotoxin limit ≤0.25 EU/mL and be produced and used under controlled conditions
• Bulk WFI is sterile by definition
• Potable water can replace WFI for LVP compounding if filtered
• WFI must always be stored at room temperature to avoid leachables

Correct Answer: Bulk Water for Injection is not sterile but must meet endotoxin limit ≤0.25 EU/mL and be produced and used under controlled conditions

Q20. How can calcium phosphate precipitation be minimized in parenteral nutrition (PN) LVPs?

• Use calcium gluconate, avoid high phosphate and prefer acetate buffer; order of mixing matters to reduce calcium phosphate precipitation
• Use calcium chloride and phosphate buffers early to maximize solubility
• High pH promotes calcium phosphate solubility in PN
• Buffer choice has no effect on precipitation

Correct Answer: Use calcium gluconate, avoid high phosphate and prefer acetate buffer; order of mixing matters to reduce calcium phosphate precipitation

Download